MyAverix Finance
STU · Healthcare
Mereo BioPharma Group plc (MAH0)
Biotechnology
Mereo BioPharma Group plc (MAH0) is listed on STU in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $37.67M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for MAH0
Mereo BioPharma Group plc (MAH0) — FAQ
What is Mereo BioPharma Group plc's market cap?
Mereo BioPharma Group plc (MAH0) has a reported market cap of $37.67M (data as of 2026-05-24).
What is MAH0's P/E ratio?
The price-to-earnings (P/E) ratio for Mereo BioPharma Group plc (MAH0) is 25.00 (data as of 2026-05-24).
Does Mereo BioPharma Group plc pay a dividend?
Dividend yield is not available in the current snapshot for Mereo BioPharma Group plc (MAH0). Check the MyAverix Finance app for the latest dividend data.
What sector is Mereo BioPharma Group plc in?
Mereo BioPharma Group plc (MAH0) is classified in the Healthcare sector (Biotechnology industry).
What exchange is MAH0 listed on?
MAH0 is listed on STU.
What is Mereo BioPharma Group plc's net margin?
Mereo BioPharma Group plc (MAH0) reports a net margin of 0.0% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.